233 related articles for article (PubMed ID: 34829389)
1. Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Immunohistochemical Analyses Using Markers for Mesonephric, Endometrioid and Serous Tumors.
Kim H; Na K; Bae GE; Kim HS
Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829389
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Immunohistochemical Analysis of Mesonephric Marker Expression in Low-grade Endometrial Endometrioid Carcinoma.
Lee Y; Choi S; Kim HS
Int J Gynecol Pathol; 2024 May; 43(3):221-232. PubMed ID: 37566876
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract.
Pors J; Cheng A; Leo JM; Kinloch MA; Gilks B; Hoang L
Am J Surg Pathol; 2018 Dec; 42(12):1596-1606. PubMed ID: 30148742
[TBL] [Abstract][Full Text] [Related]
4. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
5. Mesonephric-like Differentiation of Endometrial Endometrioid Carcinoma: Clinicopathological and Molecular Characteristics Distinct from Those of Uterine Mesonephric-like Adenocarcinoma.
Park S; Bae GE; Kim J; Kim HS
Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441384
[TBL] [Abstract][Full Text] [Related]
6. Mesonephric-like Adenocarcinoma of the Ovary: Clinicopathological and Molecular Characteristics.
Koh HH; Park E; Kim HS
Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204416
[TBL] [Abstract][Full Text] [Related]
7. Mesonephric-like Endometrial Carcinoma: Results From Immunohistochemical Screening of 300 Endometrial Carcinomas and Carcinosarcomas for This Often Overlooked and Potentially Aggressive Entity.
Mills AM; Jenkins TM; Howitt BE; Fan J; Ring KL; Cook I
Am J Surg Pathol; 2022 Jul; 46(7):921-932. PubMed ID: 35195579
[TBL] [Abstract][Full Text] [Related]
8. Mesonephric-Like Adenocarcinoma of Uterine Corpus: A Clinicopathological and Targeted Genomic Profiling Study in a Single Institution.
Ma T; Chai M; Shou H; Ru G; Zhao M
Front Oncol; 2022; 12():911695. PubMed ID: 35865471
[TBL] [Abstract][Full Text] [Related]
9. Ovarian Combined Serous Borderline Tumor/Low-grade Serous Carcinoma and Mesonephric-like Lesion: Report of 2 Cases With New Observations.
Nilforoushan N; Liu L; Finkelman BS; Andersen J; Liu Y; James J; Hung CF; Wu TC; Vang R; Xing D
Int J Gynecol Pathol; 2023 Mar; 42(2):182-191. PubMed ID: 35348533
[TBL] [Abstract][Full Text] [Related]
10. [Proliferative lesions with mesonephric features in the gynecologic tract: a clinicopathological analysis of sixteen cases].
Mo N; He CY; Yu HY; Bian XT; Jin YL
Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):1000-1006. PubMed ID: 36207913
[No Abstract] [Full Text] [Related]
11. Corded and hyalinized mesonephric-like adenocarcinoma of the uterine corpus: report of a case mimicking endometrioid carcinoma.
Patel V; Kipp B; Schoolmeester JK
Hum Pathol; 2019 Apr; 86():243-248. PubMed ID: 30172914
[TBL] [Abstract][Full Text] [Related]
12. Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma.
McCluggage WG; Vosmikova H; Laco J
Int J Gynecol Pathol; 2020 Jan; 39(1):84-92. PubMed ID: 30575604
[TBL] [Abstract][Full Text] [Related]
13. Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Analyses of Clinicopathological, Molecular, and Prognostic Characteristics With Retrospective Review of 237 Endometrial Carcinoma Cases.
Kim HG; Kim H; Yeo MK; Won KY; Kim YS; Han GH; Kim HS; Na K
Cancer Genomics Proteomics; 2022; 19(4):526-539. PubMed ID: 35732320
[TBL] [Abstract][Full Text] [Related]
14. Serous Carcinoma of the Endometrium with Mesonephric-Like Differentiation Initially Misdiagnosed as Uterine Mesonephric-Like Adenocarcinoma: A Case Report with Emphasis on the Immunostaining and the Identification of Splice Site
Choi S; Jung YY; Kim HS
Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33919505
[TBL] [Abstract][Full Text] [Related]
15. [Adenocarcinomas with mesonephric features in gynecologic tract: a clinicopathological analysis of seven cases].
Liang Y; Ruan HJ; Wang WS; Yu MH; Chen XD; Zhang XF
Zhonghua Bing Li Xue Za Zhi; 2021 Jul; 50(7):791-795. PubMed ID: 34405616
[No Abstract] [Full Text] [Related]
16. Mesonephric-like adenocarcinoma harbours characteristic copy number variations and a distinct DNA methylation signature closely related to mesonephric adenocarcinoma of the cervix.
Kommoss FK; Lee CH; Tessier-Cloutier B; Gilks CB; Stewart CJ; von Deimling A; Köbel M
J Pathol; 2024 Jan; 262(1):4-9. PubMed ID: 37850576
[TBL] [Abstract][Full Text] [Related]
17. Mesonephric Adenocarcinoma and Mesonephric-like Adenocarcinoma of the Urinary Tract.
Xing D; Liang SX; Gao FF; Epstein JI
Mod Pathol; 2023 Jan; 36(1):100031. PubMed ID: 36788068
[TBL] [Abstract][Full Text] [Related]
18. Differential Expression Patterns of GATA3 in Uterine Mesonephric and Nonmesonephric Lesions.
Roma AA; Goyal A; Yang B
Int J Gynecol Pathol; 2015 Sep; 34(5):480-6. PubMed ID: 25851711
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Value of Immunostaining for Thyroid Transcription Factor 1 (TTF1) and Paired Box 8 (PAX8) in Distinguishing Pulmonary Metastases of Mesonephric and Mesonephric-like Adenocarcinomas from Primary Lung Adenocarcinomas.
Ji N; Lee Y; Lee SH; Kim HS
Anticancer Res; 2024 May; 44(5):2159-2170. PubMed ID: 38677751
[TBL] [Abstract][Full Text] [Related]
20. Mesonephric Adenocarcinoma of the Uterine Corpus: A Case Report and Diagnostic Pitfall.
Kim SS; Nam JH; Kim GE; Choi YD; Choi C; Park CS
Int J Surg Pathol; 2016 Apr; 24(2):153-8. PubMed ID: 26510860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
